Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice

Clinical Cancer Research

Volumn 4, Issue 12, 1998, Pages 2957-2966

  Prewett, Marie ^a   Rothman, Marc ^a   Waksal, Harlan ^a   Feldman, Michael ^a   Bander, Neil H ^b   Hicklin, Daniel J ^a  

^a ELI LILLY AND COMPANY   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CHIMERIC ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; KIDNEY CARCINOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RECEPTOR BINDING; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; CELL DIVISION; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0032407024     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Motzer, R. J., Bander, N., and Nanus, D. M. Renal-cell carcinoma. N. Engl. J. Med., 335: 865-875, 1996.
2. Rabinovitch, R. A., Zelefsky, M. J., Gaynor, J. J., and Fuks, Z. Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systematic therapy. J. Clin. Oncol., 12: 206-212, 1994.
3. Thrasher, J. B., and Paulson, D. F. Prognostic factors in renal cancer. Urol. Clin. N. Am., 20: 247-261, 1993.
4. Hofmockel, G., Tack, W., and Frohmüller, H. G. W. Cyclic Interferon a treatment in metastatic renal cell carcinoma: results of a phase II study and review of the literature. Urol. Int., 58: 8-12, 1997.
5. Gleave, M. E., Elhilali, M., Fradet, Y., Davis, I., Venner, P., Saad, F., Klotz, L. H., Moore, M. J., Paton, V., and Bajamonde, A. Interferon γ-1b compared with placebo in metastatic renal-cell carcinoma. N. Engl. J. Med., 338: 1265-1271, 1998.
6. Negrier, S., Escudier, B., Lasset, C., Douillard, J-Y., Savary, J., Chevreau, C., Ravaud, A., Mercatello, A., Peny, J., Mosseau, M., Philip, T., and Tursz, T. Recombinant human interleukin-2, recombinant human Interferon α-2a, or both in metastatic renal-cell carcinoma. N. Engl. J. Med., 338: 1272-1278, 1998.
7. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203-212, 1990.
8. Modjtahedi, H., and Dean, C. The receptor of the EGF and its ligands: expression, prognostic value and target for therapy in cancer. Int. J. Oncol., 4: 277-296, 1994.
9. Kim, H. H., Sierke, S. L., and Koland, J. G. Epidermal growth factor dependent association of phosphatidylinositol-3-kinase with the erbB-3 gene product. J. Biol. Chem., 269: 24747-24755, 1994.
10. Plowman, G. D., Whitney, G. S., Neubauer, M. G., Green, J. M., McDonald, V. L., Todaro, G. J., and Shoyab, M. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc. Nat. Acad. Sci. USA, 87: 4905-4909, 1990.
11. Hartmann, L., Ingle, J. N. Wold, L. E., Farr, G. H., Grill, J. P., Su, J. Q., Maihle, N. J., Krook, J. E., Witzig, T. E., and Roche, P. C. Prognostic values of c-erbB-2 overexpression in axillary lymph node positive human cancer. Cancer (Phila.), 74: 2956-2963, 1994.
12. Sainsbury, J. R. C., Sherbert, G. V., Farndon, J. R., and Harris, A. L. Epidermal growth factor receptors and estrogen receptors on human breast cancer. Lancet, 10: 364-366, 1985.
13. Eisbruch, A., Thick, M., Lee, J. S., Sacks, P. G., and Gutterman, J. Analysis of epidermal growth factor gene in fresh human head and neck tumors. Cancer Res., 47: 3603-3605, 1987.
14. Neal, D. E., Bennett, M. K., Hall, R. R., March, C., Abel, P. D., Sainsbury, J. R. C., and Harris, A. L. Epidermal growth factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet, 11: 366-368, 1985.
15. Humphrey, P. A., Wong, A. J., Friedman, H. S., Werner, M. H., Bigner, D. D., and Bigner, S. H. Amplification and expression of the epidermal growth factor receptor in human glioblastoma xenografts. Cancer Res., 48: 2231-2238, 1988.
16. Rusch, W., Baselga, J., Cordon-Cardo, C., Orazen, J., Zaman, M., Hoda, S., McIntosh, J., Kurie, J., and Dmitrovsky, E. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign luna. Cancer Res., 53: 2379-2385, 1993.
17. Cohen, D. W., Simak, R., Fair, W. R., Melamed, J., Scher, H. I., and Cordon-Cardo, C. Expression of transforming growth factor-α and the epidermal growth factor receptor in human prostate tissues. J. Urol., 752: 2120-2124, 1994.
18. Ethier, S. Growth factor synthesis and human breast cancer progression. J. Natl. Cancer Inst., 87: 964-973, 1995.
19. Jardines, L., Weiss, M., Fowble, B., and Greene, M. Neu (c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer. Pathobiology, 61: 268-282, 1993.
20. Uhlman, D. L., Nguyen, P., Manivel, J. C., Zhang, G., Hagan, K., Parley, E., Aeppli, D., and Niehans, G. Epidermal growth factor receptor and transforming growth factor a expression in papillary and non-papillary renal cell carcinoma: correlation with metastatic behavior and progress. Clin. Cancer Res., 1: 913-920, 1995.